Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease

Project: Research

Project Details

StatusActive
Effective start/end date11/12/25 → 06/1/27

Funding

  • Pharmaceutical Research Associates Incorporated: $6,604.00